Gujarat State Leadership Awards 2023 – Cadila wins two awards, “Most Admired Company of the Year” and “Best Employer Brand of the Year”.
Cadila Pharmaceuticals received the “Most Admired Company of the Year” and “Best Employer Brand of the Year” awards. The awards were presented to Cadila Pharmaceuticals for its exceptional contribution to the pharmaceutical industry and its impact on the employment landscape in Gujarat.
Mr. Santosh Vyas from Cadila Pharmaceuticals’ Corporate Communications department received the awards on behalf of the company.
“We are honoured to receive these awards, which reflect our commitment to meeting the healthcare needs of patients in India and globally and promoting an environment where employees can thrive and enjoy their work. These awards will serve as an inspiration for us to continue our journey towards excellence and innovation with care . We extend our sincere appreciation to all employees and partners for their continuous support, which has been instrumental in achieving these awards. ” said Mr. Kinjal Choudhary, Global President HR at Cadila Pharmaceuticals.
Cadila Pharmaceuticals remains committed to its mission of making a positive and lasting impact on healthcare and society and continuing to set new benchmarks in the pharmaceutical industry. Cadila Pharmaceuticals Ltd. is one of India’s leading integrated privately held pharmaceutical firms, located in Ahmedabad, Gujarat. The firm develops and produces pharmaceutical products in India and sells and distributes them in over 100 countries. The organization places a high emphasis and priority on research, whether it is in biotechnology, APIs, formulations, plant tissue culture or phytochemistry to innovate in various therapeutic areas including gastrointestinal, cardiology, pulmonary, oncology, gynaecology, cardiovascular, Diabetology, and osteology. Its undaunted commitment to create affordable miracles in therapeutic areas with significant unmet medical needs to serve the society & community at large, has led to several world-first breakthroughs.